Stand Up To Cancer Canada

Stand Up To Cancer Canada (SU2C Canada), a program of the Entertainment Industry Foundation Canada, aims to build broad support for a groundbreaking “translational” research model that can produce meaningful advances in cancer treatment.  With the goal of accelerating the pace at which new therapies get to patients, SU2C Canada enables leading scientists in different disciplines from multiple institutions to work together.

As the scientific partner of SU2C Canada, AACR International – Canada provides expert peer review, grants administration, and scientific oversight to the SU2C Dream Teams that seek to push forward innovative cancer research.

The review of the Dream Teams is conducted via a rigorous yet rapid, flexible and transparent process led by a Canadian Scientific Advisory Committee (CSAC) composed of prominent researchers and co-chaired by Nobel Laureate Phillip A. Sharp, PhD, Institute Professor at the David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT), and Alan Bernstein, OC, PhD, FRSC, President and CEO of the Canadian Institute for Advanced Research (CIFAR).